Cite
MLA Citation
Anders Österborg et al.. “Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.” Leukemia & lymphoma, vol. 57, no. 9, n.d., pp. 2037–2046. http://access.bl.uk/ark:/81055/vdc_100034566536.0x00003e